Last reviewed · How we verify
Blood-stage controlled human P. falciparum malaria infection — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Blood-stage controlled human P. falciparum malaria infection (Blood-stage controlled human P. falciparum malaria infection) — University of Oxford.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood-stage controlled human P. falciparum malaria infection TARGET | Blood-stage controlled human P. falciparum malaria infection | University of Oxford | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood-stage controlled human P. falciparum malaria infection CI watch — RSS
- Blood-stage controlled human P. falciparum malaria infection CI watch — Atom
- Blood-stage controlled human P. falciparum malaria infection CI watch — JSON
- Blood-stage controlled human P. falciparum malaria infection alone — RSS
Cite this brief
Drug Landscape (2026). Blood-stage controlled human P. falciparum malaria infection — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-stage-controlled-human-p-falciparum-malaria-infection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab